(Q81236488)
Statements
PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study (English)
Guillermo Garcia-Manero
Jorge Cortes
Francis Giles
Elias Jabbour
Hagop Kantarjian
Deborah Thomas
Alessandra Ferrajoli
Stefan Faderl
Miloslav Beran
1 November 2007